Diversity In Clinical Trials: How Companies Are Tackling The Issue

Life sciences companies are working to increase diversity in clinical trials, addressing the underrepresentation of historically underserved populations. In aiding these efforts, Genentech is providing financial support to communities promoting inclusive research and has created dedicated roles to support this goal. Genentech is also part of TransCelerate’s Diversity of Participants in Clinical Trials initiative, which aims to boost the representation of racial and ethnic minorities in industry-sponsored clinical trials.

This article highlights the potential of technology, particularly smartphones, to democratize access to healthcare data and services, and the importance of collaboration within the pharmaceutical industry. Examples include Bristol Myers Squibb and Genentech investing millions in programs aimed at increasing diversity in clinical trials. Learn more about how collaborative approaches, involving technology and multiple resources, can improve health outcomes and move towards increased diversity in clinical trials by accessing the article below.